Sinopharm Group Co.-Unsp ADRSHTDY
13F holders, Q4 2024 (December 31)3holders −1
0new positions
1sold out
$13.57avg. 13F price*
At the end of Q4 2024, 3 institutions reported holding Sinopharm Group Co.-Unsp ADR (SHTDY) in their 13F filings, down 1 from Q3 2024. 0 opened new positions and 1 sold out. The largest holders were Rhumbline Advisers ($15K), PNC Financial Services Group, Inc. ($3K) and GAMMA Investing LLC ($3K).
- Company
- Sinopharm Group Co.-Unsp ADR
- CUSIP
- 82937K101
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 1 | $4K |
All 13F filers, Q3 2024 → Q4 2024: 33 shares bought and 294 shares sold, net −261 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 3 holders
| Rhumbline Advisers | 0.00% | No change | 1,101 | $15K |
| PNC Financial Services Group, Inc. | 0.00% | Add +14.8% | 256 | $3K |
| GAMMA Investing LLC | 0.00% | No change | 205 | $3K |
"% of holder's portfolio" is SHTDY's weight in each manager's 13F, not the share of Sinopharm Group Co.-Unsp ADR the manager owns.